Pre-market
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/TSX-V/NTLX

NeuroThera Labs Inc. (NTLX : TSX-V)

Common Stock

$3.36

CAD

+3.05 (1001.64%)

Last updated: 2026-09-01

Get NTLX alerts:

NTLX

NeuroThera Labs Inc.

Source:WealthAwesomeWealthAwesome
$3.18 (1766.67%)
30 day period
$0.16$1.76$3.36Jun 10Jul 2Sep 1

Performance

1 Day

+1001.64%

1 Week

+784.21%

1 Month

+1427.27%

YTD

+1876.47%

Key Statistics

Market Cap

$25.89M

52W High

$0.38

52W Low

$0.15

P/E Ratio

-

50 Day MA

$0.23

200 Day MA

$0.20

Beta

-0.20

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
9/1/2026$3.22$3.36$3.22$3.36$3.361,714
8/31/2026$0.30$0.30$0.30$0.30$0.306,000
8/25/2026$0.34$0.38$0.34$0.38$0.3876,000
8/20/2026$0.34$0.34$0.34$0.34$0.341,000
8/17/2026$0.32$0.35$0.32$0.35$0.3574,500
8/11/2026$0.30$0.33$0.30$0.33$0.33102,000
8/7/2026$0.23$0.29$0.23$0.29$0.2956,000
8/6/2026$0.24$0.24$0.24$0.24$0.2425,000
7/31/2026$0.22$0.22$0.22$0.22$0.2220,000
7/30/2026$0.23$0.24$0.23$0.24$0.2432,500

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on NTLX's historical volatility

HistoricalForecast68%95%
C$0.00C$3673.31C$7346.63C$11019.94C$14693.25C$18366.57TodayMar 12May 20Sep 1Oct 14Nov 27Jan 9

30-Day Vol

702.6%

Annualized

90-Day Vol

430.8%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$4.02

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$3.57C$0.32C$40.28
60 trading daysC$3.78C$0.12C$116.69
90 trading daysC$4.02C$0.06C$267.63

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About NeuroThera Labs Inc.

Neurothera Labs Inc. engages in the development of a portfolio of drugs based on cannabinoid molecules. The company develops programs based on tetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol for the treatment of Tourette syndrome, Alzheimer's disease and agitation, autism spectrum disorder, and status epilepticus. It also focuses on e-commerce operations, which sells hemp-based products. Neurothera Labs Inc. was formerly known as Miza III Ventures Inc. The company is based in Newark, Delaware. Neurothera Labs Inc. is a subsidiary of SciSparc Ltd.

Financials

Revenue (TTM)
$856,000
EBITDA
$-2.54M
Profit Margin
0.00%
ROE (TTM)
-399.18%
EPS (Diluted)
-0.08
Book Value
0.00

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About NTLX

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
ADJ-PAD4 Capital Corp.$0.30+200.00%
ISGIInsuraGuest Technologies Inc$0.01+100.00%
MTLOMartello Technologies Group Inc$0.01+100.00%
MXL-HMX Gold Corp$0.05+66.67%
AUMEAuriginal Mining Corp.$0.08+60.00%
GVRGrosvenor Resource Corp$0.07+55.56%
PULPulse Oil Corp$0.01+50.00%
UNO-HNorthern Uranium Corp$0.17+37.50%

NTLX.V news timeline

2 articles covering NTLX.V, most recent first

Latest

Why NeuroThera Labs Inc. stock plummeted yesterday

Stocks

Advertisement